Intracellular Protein Therapeutics (IPT) Platform

About Xpamac

Xpamac is an early-stage biotech company offering cell line development services and technology to improve the manufacturing of complex biologics. Its core innovation is the XPAMAC Technology, which uses Mammalian Elongated Chromosomes (MEC) to enable stable, high-yield protein expression in CHO and HEK293 cells, aiming to solve manufacturing bottlenecks. Founded by venture capitalists and scientists from Szeged, the company is pre-revenue and actively seeking partnerships with biopharma firms and CDMOs to commercialize its platform.